Galera Therapeutics, Inc. (GRTX)

NASDAQ: GRTX · IEX Real-Time Price · USD

0.194

+0.004 (2.00%)

At close: May 2, 2024, 4:00 PM

0.192

-0.002 (-0.83%)

Pre-market: May 3, 2024, 5:46 AM EDT

Galera Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	Current	2023	2022	2021	2020	2019
Market Capitalization	11	8	42	121	255	326
Market Cap Growth	-	-81.38%	-65.01%	-52.46%	-21.81%	-
Enterprise Value	-6	-9	11	50	183	215
PE Ratio	-0.13	-0.13	-0.68	-1.51	-3.44	-5.52
PB Ratio	-0.06	-0.06	-0.39	-2.09	41.72	4.69
P/FCF Ratio	-0.18	-0.18	-0.98	-1.78	-4.25	-6.90
P/OCF Ratio	-0.18	-0.18	-0.98	-1.79	-4.29	-7.00
EV/EBITDA Ratio	0.19	0.19	-0.21	-0.70	-2.65	-4.42
EV/EBIT Ratio	0.19	0.19	-0.21	-0.69	-2.64	-4.40
EV/FCF Ratio	0.20	0.20	-0.25	-0.74	-3.05	-4.55
Debt / Equity Ratio	-0.01	-0.01	0.00	-0.01	0.09	0.01
Debt / EBITDA Ratio	-0.03	-0.03	0.00	0.00	-0.01	-0.02
Debt / FCF Ratio	-0.03	-0.03	0.00	0.00	-0.01	-0.02
Quick Ratio	3.68	3.68	2.37	5.51	5.21	11.58
Current Ratio	4.36	4.36	2.88	5.98	5.58	12.13
Interest Coverage	-4.18	-4.18	-4.38	-10.19	-14.21	-16.14
Return on Equity (ROE)	50.20%	50.20%	69.10%	234.70%	-239.20%	335.70%
Return on Assets (ROA)	-137.50%	-137.50%	-109.70%	-87.60%	-69.50%	-55.90%
Return on Capital (ROIC)	37.91%	37.91%	46.94%	127.15%	-1060.63%	-71.96%
Earnings Yield	-561.07%	-747.06%	-146.53%	-66.36%	-29.08%	-18.10%
FCF Yield	-426.45%	-567.82%	-102.32%	-56.23%	-23.50%	-14.49%
Buyback Yield / Dilution	-64.47%	-64.47%	-5.03%	-3.70%	-586.06%	-1105.94%
Total Shareholder Return	-64.47%	-64.47%	-5.03%	-3.70%	-586.06%	-1105.94%

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).